Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G-quadruplexes (G4s) are non-canonical, four-stranded secondary structures formed by guanine-rich sequences in DNA and RNA [1, 3]. These structures are stabilized by Hoogsteen hydrogen bonding between four guanine bases, forming planar G-tetrads that stack on top of each other, often coordinated by a central potassium or sodium cation [3, 9]. G4s are prevalent in functionally significant genomic regions, including telomeres, oncogene promoters (such as c-MYC, c-KIT, and KRAS), and the untranslated regions (UTRs) of mRNA [4, 5]. They play critical roles in regulating essential cellular processes like gene transcription, translation, DNA replication, and telomere maintenance [1, 9]. In disease contexts, particularly cancer, G4 stabilization can repress the expression of potent oncogenes or inhibit telomerase activity, leading to cell cycle arrest or apoptosis [1, 11]. Small molecule ligands designed to target G4s, such as Pidnarulex (CX-5461), are being investigated for their ability to induce synthetic lethality in DNA repair-deficient cells, such as those with BRCA1/2 mutations [11]. RNA G-quadruplexes (rG4s) are also emerging as targets for their roles in mRNA splicing and translation regulation, particularly in neurodegenerative diseases like ALS [5, 8]. However, achieving high selectivity for specific G4 topologies over others remains a significant therapeutic challenge due to the structural similarity of different G4 motifs [2, 10].
Stabilization of G-quadruplex structures to inhibit transcription of oncogenes, interfere with telomere maintenance, or induce DNA damage and synthetic lethality.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-quadruplex DNA and RNA structures (G4).